India rejects Novartis patent plea »

Share on Facebook

Share on Twitter

India's Supreme Court rejects a plea by Swiss company Novartis to patent an updated version of its cancer drug, Glivec. Source Main page (current trends)

More about: india, novartis, patent, Supreme Court

Share on Facebook

Share on Twitter

Your comments